Ertahil Sit 5/100mg Tablet – Ertugliflozin 5mg + Sitagliptin 100mg
Ertahil Sit 5/100mg Tablet – Ertugliflozin 5mg + Sitagliptin 100mg
Ertahil Sit 5/100mg Tablet – Ertugliflozin 5mg + Sitagliptin 100mg
Description
Ertahil Sit 5/100mg Tablet – Gentle Dual-Action Once-Daily Tablet for Better Glycemic Control
Ertahil Sit 5/100mg Tablet combines ertugliflozin 5 mg (SGLT2 inhibitor) and sitagliptin 100 mg (DPP-4 inhibitor) in one convenient pill to effectively manage type 2 diabetes in adults. Ertugliflozin removes excess glucose through urine while sitagliptin enhances natural incretin hormones to boost insulin release and lower liver glucose production only when needed. This lower-dose ertugliflozin combo is ideal for patients starting combination therapy or those who need cardiovascular & kidney protection with a gentler SGLT2 effect. It delivers significant HbA1c reduction, modest weight loss, very low hypoglycemia risk, and proven heart & kidney benefits – all with once-daily simplicity.
